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Abstract
Background: At a primary care center in Brooklyn, New York, approximately 27% of
diabetic patients with abnormal Hgb A1C fail to return for follow-up appointments, as
recommended by the Centers for Disease Control and Prevention (CDC). According to
electronic medical records (EMR), healthcare providers demonstrated inconsistency in
ordering and monitoring Hgb A1C and clinic follow-up appointments for patients.
Purpose: The purpose of this quality improvement project was to determine
retrospectively the healthcare providers’ ordering, monitoring, and follow-up
appointments for adult diabetic patients with abnormal Hgb A1Cs; to develop and
implement a standardized process for healthcare providers to monitor and follow these
patients, especially those with possible nonclinic follow-up compliance and abnormal
Hgb A1C; to determine prospectively healthcare providers’ ordering, monitoring, and
follow-up appointments; and to evaluate the prospective charts to determine if Hgb AIC
results changed from abnormal to normal or elevation over time until the next follow-up
appointment.
Theoretical Framework: The theoretical framework was the nursing practice model,
which allows clinical systems to redesign operational processes associated with patient
care for innovative clinical advancement outcomes.
Methods: Frequency tests were used to determine appointment adherence retrospectively
and prospectively, with a convenience sample of seven healthcare providers and review
of 99 retrospective and prospective medical records of diabetic patients who met
inclusion criteria. A nonparametric quantitative paired t test was used to measure patients
diagnosed with poorly controlled diabetes who were treated over two 3-month timespans.
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Results: The difference in A1C scores between the two 3-month periods ranged from 4.5
to 2, with an average improvement of -1.32. These scores reflected an improvement in
healthcare providers’ ordering and monitoring of Hgb A1C after CDC-implemented
standardized guideline and recommendations.
Conclusion: The lack of appropriate healthcare provider management of diabetic
patients can lead to additional health complications. Monitoring of patients’ Hgb A1C
levels through prospective electronic medical record reviews is a simple yet viable
approach. With this approach, healthcare practitioners can improve ordering and
monitoring of Hgb A1C for normalcy and follow-up consistency after implementation of
standardized practice.
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Managing Diabetic A1c at A Primary Care Center:
A Nurse Practitioner Perspective
Chapter 1
Nature of Project and Problem Identification
Diabetes rates in the United States (U.S.) have risen to epidemic proportions. In
2015, approximately 30.3 million people of all ages, nearly 10% of the population, were
diagnosed for diabetes. In the same year, 33.9% of U.S. adults aged 18 years or older
(84.1 million people) had prediabetes (Centers for Disease Control and Prevention
[CDC], 2017). Diabetes affects individuals of all ages, but it is most prevalent among
those 65 years and older (American Diabetes Association [ADA], 2016). It has been
predicted that by 2050, diabetes will affect as many as one in three American adults.
In 2010, diabetes was identified as the seventh leading cause of death but, as
diabetes leads to several severe comorbidities, it is listed as a contributing cause of death
to many more. Comorbidities that frequently coexist with diabetes include hypertension,
dyslipidemia, nonalcoholic fatty liver disease, cardiovascular disease, kidney disease, and
obesity (Centers for Disease Control and Prevention [CDC], 2011). The disease process
of diabetes damages blood vessels of all types and the organs to which blood flows.
People who have diabetes are at a higher risk than nondiabetics for developing infections,
cardiovascular disease, kidney failure, lower-limb amputation, and blindness. Other
conditions such as nerve damage, damage to teeth and gums, and sexual dysfunction are
additional comorbidities that result from diabetes
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(International Diabetes Federation, 2017; National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK, 2014).
For diabetics, lack of proper monitoring of blood glucose levels leads not only to
the diseases and conditions listed above, but also lack of proper blood glucose level
monitoring can be fatal due to coma or hard-to-treat infections (National Institute of
Diabetes and Digestive and Kidney Diseases [NIDDK], 2017). The importance of
monitoring blood glucose levels makes it imperative that blood not only be monitored
daily but also should also be monitored based on how glucose is metabolized over a
period of time. The incidence of complications of diabetes can be reduced through
careful management directed at maintaining glycemic control in adult, non-gestational
individuals with type 2 diabetes at a target Hgb A1C level of less than 7% (American
Diabetes Association [ADA], 2014). This target level can be achieved with Hgb A1C
testing, which can be enhanced through the use of a systematic/team approach.
Diabetes management requires the cooperative activities of an interprofessional
healthcare team. Diabetes is a chronic disease that is increasing locally and globally and
is a leading cause of disability. Diabetes is costly to society in terms of dollars and
human suffering (American Diabetes Association [ADA], 2013). The ill effects of
diabetes can be largely reduced through consistent monitoring of Hgb A1C and the
timely implementation of interventions to reduce the Hgb A1C among patients whose
diabetes is poorly controlled.
Currently there is a lack of standardization in ordering Hgb A1C testing for
diabetic management in a primary care center in Brooklyn, New York. As a result,
patients do not receive timely modification of their treatment plans, the Hgb A1C
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continues to be in the unacceptable range, and patients frequently suffer serious adverse
consequences.
The investigator is a family nurse practitioner at this primary care center, in which
healthcare providers serve a large population of Caribbean Americans at risk for various
chronic diseases, especially diabetes. A challenge is evident with care continuity among
these patients. The care of approximately 500 of these patients is undertaken by the
family nurse practitioners (FNP) who partner with medical providers (i.e., medical
doctors [MDs]). Of those patients seen and cared for at the clinic, 80% are diagnosed
with type 2 diabetes mellitus (T2DM), and approximately 75% of these patients
diagnostically have unacceptable Hgb A1C or fasting blood glucose levels. Some of
these patients are 50 years old, but in many cases they have developed diabetic
neuropathy, which is found in higher prevalence in the elderly population (Cleveland
Clinic, 2018). Furthermore, 60% of these patients (300) suffer from other comorbidities,
including hypertension and high blood cholesterol levels.
In spite of diabetes and comorbidities, a portion of the patients do not adhere
consistently to clinic follow-up appointments, and they sporadically cancel scheduled
appointments. The gap associated with care inconsistency stems from missed follow-up
appointments and the lack of required Hgb A1C testing, as recommended by the Centers
for Disease Control and Prevention (CDC, [2016]) for standardization of healthcare
providers’ practice and patient outcomes. The gap revealed through providers’
documentation in electronic medical records (EMR) that some patients’ Hgb A1C tests
were missed or inconsistently ordered, contrary to recommendations by the CDC (2016).
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Problem Statement
Approximately 27% of patients with an abnormal Hgb A1C at a primary care
center in Brooklyn, New York, fail to return for follow-up appointments within the
recommended CDC 3-month period.
Purpose Statement
The purpose of this quality improvement project was to determine retrospectively
the healthcare providers’ ordering, monitoring, and follow-up appointments for adult
diabetic patients with abnormal Hgb A1Cs; to develop and implement a standardized
process for healthcare providers to monitor and follow these patients, especially those
with possible nonclinic follow-up compliance and abnormal Hgb A1C; to determine
prospectively healthcare providers’ ordering, monitoring, and follow-up appointments;
and to evaluate the prospective charts to determine if Hgb AIC results changed from
abnormal to normal or elevation over time until the next follow-up appointment.
Project Objectives
The following were the objectives for this project:
1. Conduct a retrospective electronic medical record review of adult diabetic
patients with abnormal Hgb A1Cs who failed to return for follow-up
appointments between March 1 and May 31, 2017, at Week 1 after IRB
approval.
2. Develop and implement a standardized process for healthcare providers to
closely monitor and follow adult diabetic patients, especially those with
possible nonclinic follow-up-compliance and abnormal Hgb A1C at Week 3.
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3. Conduct a prospective electronic medical record review of the same Hgb A1C
abnormal adult diabetic patients as the retrospective review. These patients
attended follow-up appointments between June 1 and August 31, 2017, at Week
12.
4. Evaluate the EMR charts prospectively to determine if the diabetic patients’ Hgb
AIC results in changes from abnormal to normal or elevation over time until the
next follow-up appointment at Week 16.
Theoretical Framework
The theoretical framework used for this project was the nursing practice model.
This model allows clinical systems to redesign their operational processes associated with
patient care for innovative clinical advancement outcomes.
Practice Model
A quality improvement guide (QI) published by the United States Department of
Health and Human Services, Health Resources and Services Administration (USHRSA,
2011) was used for standardized nursing services at the patient care and nursing unit
levels for organizational best outcomes. USHRSA (2011) defined the QI as “systematic
and continuous actions that lead to measurable improvements in healthcare services and
the health status of targeted patients” (p. 1). The QI guide assists organizations in using
systems and processes that focus on patients, team building, and data analysis before and
after changes. The model illustrates the outcomes of nursing service, practice,
collaboration, communication, and professional development as related to patient-familycentered care.
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As outlined in Figure 1, the model’s principles frame the system approach used
for this project. The QI guide describes the systems, processes, and resources which will
be used; the activities or processes which will be carried out; and the projected results or
inputs processes and outputs.
Inputs

Activities
(Processes)

Inputs

Nurses (APRNs and
RNs)

Education about Hgb
A1C testing

Nurses (APRNs and
RNs)

Medical doctors

Monitoring for
patients’ Hgb A1C
levels with
retrospective and
prospective chart
reviews (EHRs)

Medical doctors

Administration
DM patients (Hgb
A1C ordering and
monitoring
inconsistency)
Electronic Medical
Records (EMR)

Monitoring
appointment
adherence

CDC standardized
practice

Administration
Diabetes mellitus
patients (Hgb A1C
ordering and
monitoring
inconsistency)

Electronic Medical
Records (EMR)
CDC standardized
practice

Figure 1. Inputs, processes, and outputs/outcomes. Adapted from USHRSA (2011), p. 2.
The Hgb A1C test is considered a safe and effective mechanism for testing blood
glucose levels. According to the USHRSA (2011), “Hgb A1C testing is a wellestablished strategy to monitor glycemic control in patients with diabetes” (p. 3). The
program will take advantage of this strategy.
According to the model, there is interdependency between the Inputs,
Activities/Processes, and Outputs in the system design of the program. All Input
individuals must be educated about Hgb A1C to understand the importance in glycemic
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control. This is a part of the Activities/Processes component of the model. Once
educated on the importance of Hgb A1C percentage for effective diabetes management,
all Input stakeholders will apply the system appropriately for monitoring. This
application should have a major effect on the Outputs of the project.
The USHRSA (2011) explanation applies to this project:
Activities or processes within a healthcare organization contain two major
components: 1) what is done (what care is provided), and 2) how it is done (when,
where and by whom care is delivered) . . . the greatest impact for QI is when both
are addressed at the same time. (p. 3)
Education to healthcare providers about the need for and use of Hgb A1C testing for
monitoring are disseminated to the healthcare team as well as the patients, for
inclusiveness and collaboration. Patients and healthcare providers are now a team.
Focus on patients. Effective QI programs must focus on patients. Proper focus
on patients comprises three major aspects. The first is providing interventions which are
safe and evidenced-based. The second is that delivery of the program must be culturally
competent, linguistically relevant, literate appropriate, and supportive for patient
engagement (USHRSA, 2011). The third is that focus on patient programs also connects
patients to other providers, as needed.
The QI program developed for this project included these elements in its design
through the use of materials targeted to the needs of the population served relating to
culture, language, and literacy levels. The support for patient engagement is inherent in
the process because of the need for constant communication between providers and
patients for the program to be maximally effective.
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Interventions to improve Hgb A1C levels, as examples of healthcare providers
connecting patients to other providers, may also include the use of exercise therapists and
dieticians or nutritionists as needed, based on patients’ Hgb A1C levels.
Focus on being part of the team. The institutional use of teamwork is becoming
more prevalent in all work environments (Mitchell et al., 2012, “Importance of
interprofessional collaboration in healthcare,” 2017). For healthcare providers to focus
on being part of the team means understanding the need for different perspectives and
respecting the contributions of all team members. Teams are most effective when the
process or system involved is complex, when solutions require creativity, when more
than one person in the organization knows all the aspects of an issue, when the process
involves more than one discipline, and when staff loyalty and buy-in are needed
(USHRSA, 2011) and when the team adheres to standardized practice (CDC, 2016).
The elements of effective teams have been supported by research studies. In a
literature review conducted by Lakhani, Benzies, and Hayden (2012) to examine the
attributes essential for effective functioning of interdisciplinary teams, the researchers
identified seven attributes; “team purpose, goals, leadership, communication, cohesion,
mutual respect and reflection” (p. E260). The current project employed these
characteristics in the program design in the following ways:
Team purpose. Effective teams have a well-defined team purpose that is
progressive and well-defined (Lakhani et al., 2012). The mission statements of most
healthcare organizations focus on a purpose statement that indicates progressiveness and
well-defined consensus. These qualities lend support to the different activities of various
teams and their purposes. The purpose for the team working on this project was to order
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Hgb A1C, monitor results, and monitor follow-up appointments to improve outcomes for
patients with diabetes and to standardize providers’ practice in accordance with
recommendations of the CDC (2016).
Goal. The primary goal was to standardize providers’ practice in relation to
diagnostic ordering, monitoring, and follow-up appointment consistency to obtain
diabetic patients’ Hgb A1C normalcy and clinic follow-up adherence.
Leadership. According to Lakhani et al. (2012), the leadership style for a
program should be democratic to encourage collaboration as a valued attribute:
“successful teams generally have a stable core” (p. E262). The leadership for this DNP
project was nurse-driven (i.e., family nurse practitioner) with a collaborative
intraprofessional team of experts in diabetic management. The nurse-driven leadership
provided feedback, education, progress reports, coaching, and mentoring for providers
caring for the diabetic population affiliated with the project.
Communication. The intraprofessional team was introduced to the
communication system that guided this DNP project. To maintain continuous
communication among all team members (FNPs, RNs, MDs, administration, and other
healthcare providers), biweekly QI meetings were held. The communication was
provided through various methods (emails, individual and/or group meetings,
GoToMeeting conferences), which often required smaller ad hoc committee meetings.
Figure 2 illustrates the nurse-driven (FNP) communication process, in accordance with
the theoretical framework.
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Theory Support
As outlined in Figure 2, a two-way communication system had previously existed
between nurses (RNs), doctors (MDs), administration, and other team members. The
nurse-driven leader (FNP) was responsible for providing continuous updates to the
intraprofessional team on the quality improvement/DNP project status, in addition to
implementing all team recommendations and modifications for project success. The
institution’s administration provided direct contact and needed resources for the project
to meet the CDC (2016) standardized recommendations for adherence to diabetic practice
and management.
Finally, the RNs networked with various referral services (i.e., other team
members) to provide a foundation for providers to order and monitor the required
services in accordance with regulatory standards. These procedures complied with the
observation of Lakhani et al. (2012): “Exchanging information and ideas allows team
members to share their expertise with one another” (p. E262). The leader of this quality
improvement/DNP project strived to be consistent in these areas of communication and
collaboration.
Cohesion. Meetings and retreats were two procedures inherent in this theoretical
framework, and thus biweekly meetings (ad hoc and/or monthly intraprofessional) and
one brainstorming retreat were implemented. The cohesion achieved from these
meetings allowed the project team and work to progress at an all-time high. Suggestions
and ideas were continuous, especially throughout project implementation. The continued
eliciting of input from members of the group through suggestion boxes, ad hoc committee
meetings, mini-assessments, and other means demonstrated that all team members agreed
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with the project objectives and their importance and were satisfied with implementing
practice change for diabetic patient management.

FNPs

MDs
RNs

Other
members of
the team
(i.e.,
dietician,
etc.)

Administration

Figure 2. Communication network (investigator-designed).
Mutual respect. The DNP project team demonstrated mutual respect for each
professional level of expertise, in accordance with the theoretical model. The team’s
respect denoted, according to the theoretical framework, the receptiveness or openness to
the differences in skills, knowledge, talents, and beliefs in addition to recognition of the
value of each member’s input (Lakhani et al., 2012). The team decided at the onset that
no tolerance would be given to disrespect, such as name calling, degrading, back-talking,
rank-and-file authority, use of profanity, harassment, and other similar forms of behavior.
Reflection. The project team first discussed professional borders and
acknowledged that various professional insights can prohibit the project’s progression if
“knowledge of self” and overwhelming personality traits were not eliminated. According
to Lakhani et al (2012), the individual or team must consider that “reflection ranges from
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thinking of an event to increased awareness of feelings, values and actions, for
considering various solutions for a problem” (p. E263). It was imperative that the project
team saw this project as an opportunity to enhance both patient outcomes and providers’
increased knowledge and implementation of standardized practice through ordering and
monitoring diabetic patients’ Hgb A1C consistently for maintaining care continuity.
Focus on the use of data. The outcome of this DNP project demonstrated the
need for diabetic Hgb AIC clinical practice modification and standardization by
providers. The data provided an overview of how clinical processes at the primary care
center worked or did not work, the need for change, and the changes that were were
needed in order to meet the CDC’s (2016) recommendations for diabetic management
and practice standardization. In addition, the data revealed what was thought to be true
existing clinical practice, established a baseline for knowledge enhancement, provided a
vehicle for monitoring care continuity challenges, and provided a vehicle for measuring
and comparing retrospective and prospective Hgb A1C performances to indicate what
changes were working. The data also revealed, as USHRSA (2011), noted, which
changes “Reduce[d]s the placement of ineffective solutions” (p. 4).
Project Significance
Nursing Practice
This project impacted how providers practice nursing. Through the
implementation of new strategies and standards, providers successfully managed patients’
Hgb A1C results and clinical follow-up appointment adherence at a primary care center
in Brooklyn, New York. The project findings established the foundation for healthcare
practitioners to standardize diabetic Hgb A1C management using the CDC (2016)
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recommendations’ in addition to incorporating evidence-based practice (EBP) to
maintain care consistency in clinical practice.
In 2012, it was estimated that individuals diagnosed with diabetes cost $245
billion in direct medical costs and reduced work productivity among the working class.
According to ADA (2013), calculation per patient with diabetes showed approximately
$13,700 each year, which was 2.3 times higher than the amount spent for persons without
diabetes. Through appropriate provider management, healthcare institutions’ costs can be
reduced through standardizing patient care and diagnostic monitoring and follow-up
consistency. Nursing practitioners, especially APRNs, can serve as the first supporters of
care continuity, as defined in the Institute of Medicine (IOM, 2014) annual report,
through care standardization, ordering, and monitoring to eradicate diabetic care
inconsistency and promote clinic follow-up adherence. These actions apply to the clinic
at which this project was conducted.
Healthcare Outcomes
Diabetes management can be enhanced through standardized practice associated
with appropriate regulatory requirements and recommendations. Healthcare providers
who adhere to standardized practice increase patient healthcare outcomes (i.e., Hgb
A1C), in addition to increasing health practice outcomes. At the primary care center
where this DNP project was conducted, the lack of standardized healthcare outcomes was
discovered by the project investigator through a retrospective review of diabetic patients’
EMR. The lack of or insufficient ordering of Hgb A1C required by CDC (2016)
recommendations and the inconsistency in scheduled follow-up appointment adherence
among persons diagnosed with diabetes produced poor health outcomes and care
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management irregularities. With changes in clinical practice, enhanced standardization,
ordering, and monitoring of Hgb A1C at the center, patients’ diagnostic outcomes
according to a prospective electronic medical record (EMR) revealed an increase in
health outcomes.
Healthcare Delivery
The healthcare delivery processes used for this project was extensive. The
processes expanded the existing practice to incorporate the CDC (2016) standardized
recommendations for consistent Hgb A1C ordering and technological monitoring for
diabetic patient management by healthcare providers. The prospective EMR revealed that
patients with elevated Hgb A1C levels who adhered to follow-up appointments and
proper healthcare provider diagnostic monitoring demonstrated reliable outcomes
throughout the delivery processes. The changes in healthcare delivery resulting from the
components of the project enhanced interdisciplinary communication and relationships
and promoted providers’ and patients’ active participation in clinical care.
Healthcare Policy
Healthcare policies are a changing paradigm that evolves as patient care needs
evolve (Sepucha, Fowler, & Mulley, 2004). Those healthcare policies that prevent,
restore, or maintain care for all healthcare arenas, especially chronic conditions such as
diabetes, influences healthcare delivery, outcomes, and practice. The results of this
project revealed that changes in existing Hgb A1C levels by integration of CDC
standards and follow-up appointment consistency changed patients’ and practice
outcomes system wide.
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Implementation of the practice changes can apply globally to other clinics and can
reduce healthcare costs of standardize care and improve patient outcomes, particularly in
diabetes, one of the most preventable health conditions (Harvard T. H. Chan School of
Public Health, 2018). This DNP project demonstrated the significance of improvement
of patients’ Hgb A1C management through enhanced provider care standardization,
monitoring, and follow-up appointment consistency.
Summary
Standardized practice, monitoring, and follow-up appointments are essential for
care management of diabetic patients at a primary care center in Brooklyn, New York.
This DNP project utilized technology (EMR) to identify gaps in care continuity and
diagnostic monitoring inconsistency in practice. The healthcare providers’ orders and
monitoring of patients’ diabetes mellitus Hgb A1C require incorporation of standardized
ordering and monitoring of Hgb A1C and reduction of inconsistent follow-up
appointments. These changes are paramount for positive practice outcome and care
continuity. Over the past two decades, literature has shown that consistent Hgb A1C
ordering and monitoring by providers is an essential procedure for diabetes management.
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Chapter 2
Review of the Literature
The purpose of this quality improvement project at a primary care clinic in
Brooklyn, New York, was to determine retrospectively the healthcare providers’
ordering, monitoring, and follow-up appointments for adult diabetic patients with
abnormal Hgb A1Cs; to develop and implement a standardized process for healthcare
providers to monitor and follow these patients, especially those with possible nonclinic
follow-up compliance and abnormal Hgb A1C; to determine prospectively healthcare
providers’ ordering, monitoring, and follow-up appointments; and to evaluate the
prospective charts to determine if Hgb AIC results changed from abnormal to normal or
elevation over time until the next follow-up appointment. For this project, several search
strategies were used with a number of databases.
Search Strategies
A literature search was conducted using the following databases: Academic
Search Premier, CINAHL-Complete, Cochrane Database of Systematic Literature
Reviews, Health Technology Assessments, Medline, and Nursing and Allied Health
Collections: Comprehensive. For search options, Boolean/Phrase, Apply Related Words,
and Also Search within Full-Text of articles were set for Search Modes and Expanders.
The type and year parameters were scholarly peer-reviewed journals and January 2009
through December 2016, as well as English language only. Additional
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sources of information were obtained from government reports and articles with the use
of Google and Google Scholar and the Joanna Briggs Institute database.
With these databases and settings, the following keywords were used alone and in
various combinations: A1C monitoring, A1C testing, blood glucose, diabetes guidelines,
improved, intervention, management, nurses, nursing, patient outcomes, and type 2
diabetes. All of these words are pertinent to the use of Hgb A1C as an assessment of
blood glucose levels and the relationship of these levels to successful diabetes
management. The overreaching themes identified in the literature were related to Hgb
A1C testing, Hgb A1C monitoring, point of care interventions, self-management of
diabetes, nurse-led interventions, hyperglycemic control, the effects of health education,
and management of diabetes.
Hgb A1C Testing
Knowledge of patients’ glycemic status as an essential component for diabetes
care and management is acknowledged by healthcare practitioners worldwide (Holt,
2014; NIDDK, 2014; Perrota et al., 2014). In addition, monitoring of blood glucose
levels is useful for diagnosing diabetes and prediabetes (ADA, 2014; Holt, 2014;
NIDDK, 2014). The importance of testing blood glucose levels using the A1C test is
related to the fact that in many cases damage is already present in the microvascular and
macrovascular systems due to high blood sugar levels prior to diabetes diagnosis (Holt,
2014; Perrota et al., 2014).
Other forms of glucose testing cannot determine the long-term measurements of
blood sugar levels as comprehensively as A1C testing (ADA, 2014; Holt, 2014; Jones,
2013; Zhou et al., 2010). Therefore, Hgb A1C testing is an essential approach for
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improving nursing and healthcare delivery and results. Hgb A1C is an applicable
diagnostic test for prediabetes and diabetes in adults (Jones, 2013). The usual course of
aging comes with a higher rate of A1C; that is, aging is generally associated with
increases in A1C levels, although diabetes can develop at any age (ADA, 2016).
Therefore, there are significant disparities may take place between Hgb A1C-based
diagnosis and fasting plasma glucose based in adults, a discrepancy influenced by gender
and race (Meneilly, Knip, & Tessier, 2013). Hence, Hgb A1C testing at earlier ages in
vulnerable populations may decrease the development of diabetes.
Hgb A1C Monitoring
Despite the effectiveness and recommendation for Hgb A1C testing for diabetes
management by the ADA and others, no mandate exists at present for its use. According
to the NIDDK (2014), Hgb A1C monitoring can be used to assess the blood glucose
levels of patients with diabetes (both types 1 and 2), and information gained can be used
for adjusting medications, as well as reduction of risks of lifelong complications.
Because of the comprehensive ability of Hgb A1C testing to measure blood glucose
levels in the long term, over the life of red blood cells (120 days), it is considered the
“gold standard” and recommended for use in the management of diabetes (Holt, 2014;
Perrota et al., 2014).
Point-of-Care Testing Intervention and Hgb A1C
According to the National Institutes of Health (NIH, 2013), point-of-care testing
(POCT) “allows patient diagnoses in the physician’s office, an ambulance, the home, the
field, or in the hospital” (p. 1). With POCT, early diagnosis and treatment decisions can
be made rapidly with the latest in information on patient status (Jones, 2013). NIH
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(2013) considered POCT as a tool of empowerment for healthcare practitioners, not only
as an enhancement of the ability to make time-sensitive decisions but also as a tool to
limit health disparities.
POCT can provide pertinent diagnostic information in one session, a quality vital
to diabetes management (Jones, 2013). Good glycemic control is indicated by a Hgb
A1C value between 6.5% and 7.5% (48-58 mmol/mol), with the nondiabetic reference
range 4.0%-6.0% (20-42 mmol/mol), providing the patients has no disabling
hypoglycemic condition. The case for using Hgb A1C monitoring as a POCT strategy
for managing diabetes is strengthened because patients can take action immediately on
the results of this test, which also increases patient satisfaction (Yang et al., 2016). Jones
(2013) conducted four observational studies involving more than 5,700 patients with
diabetes, where immediate feedback of their Hgb A1C status was provided. Jones (2013)
found significant reductions in Hgb A1C levels, with one patient maintaining appropriate
A1C status for more than 4 years
According to Meetoo and Wong (2015), use of the Hbg A1C test for diabetes
management is also fiscally sound. According to the results of studies conducted by
Snellman and Eckerborn (1997) and Pluddemann, Heneghan, Price, Wolstenholme, and
Thompson (2011), the benefits of implementing Hgb A1C testing at home were fewer
clinic visits, reduction in labor costs and travel time, and overall reduction in the costs of
diabetes management. As in the study by Jones (2013), Meeto and Wong (2015) found
that use of the Hgb A1C test for monitoring of blood glucose levels also increased
customer satisfaction and better adherence to treatment regimens. Both Jones (2013) and
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Meetoo and Wong (2015) stressed administration of a Hgb A1C test every 3 months as
essential for effective monitoring of diabetic patients as part of a POCT intervention.
Self-Management and Knowledge of Hgb A1C Test
Self-management of any disease is generally enhanced when patients understand
the reasons why they should engage in a treatment or a test (Meetoo & Wong, 2015). For
patients, management of a chronic disease requires knowledge, discipline, and
encouragement from a team of professionals. Patients’ knowledge of why they should
engage in a test and the meaning of a test has been studied in relationship to self-care
levels and knowledge of a disease and how it affects patient health.
Heisler, Piette, Spencer, Kieffer, and Vijan (2005) conducted a cross-sectional
survey with a sample of 686 U.S. adults diagnosed with type 2 diabetes in five health
systems. The hypothesis was that knowledge of their actual and target health outcomes
(such as Hbg A1C values) was a prerequisite for effective patient involvement in
management of chronic diabetes. The patients had checked in 6 months before the study
and their Hbg AlC levels recorded.
Based on multivariate analysis, which analyzed patient characteristics, healthcare
provider communication, and health system type, the results of the study showed that
66% of the respondents did not know their last Hbg A1C values, and 25% were able to
accurately report their values. Respondents who did know their last Hbg A1C values
were better able to accurately assess their diabetes control. Higher evaluations of
provider communication ability were independently associated with knowledge of Hbg
A1C. However, knowledge of Hbg A1C had no effect on self-efficacy or reported selfmanagement behaviors in this study (Heisler et al., 2005).
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Additional studies on knowledge of the meaning of Hgb A1C and the importance
of knowledge of laboratory test with regard to self-care and successful glycemic control
have also been conducted in other countries. In a cross-sectional survey conducted at 50
medical centers in various locations in China, researchers proposed that Hgb A1C
knowledge is a prerequisite for effective self-management. Participants were asked “How
long does A1c reflect average blood glucose level?” and “What is the recommended A1C
level by Chinese Diabetes Society guideline?” (Yang et al., 2016, p. 4).
A higher quantity of patients with well-controlled diabetes was identified as
having a “good understanding” of Hgb A1C (Yang et al., 2016, p. 9). In addition,
patients in the “good understanding” group were more likely to perform self-monitoring
of blood glucose than those in the “poor understanding” group and also reported higher
average self-care scores in the preceding 7 days than the “poor understanding” group
(p. 9).
In a similar study conducted in Trinidad and Tobago (Ezenwaka et al., 2014), 89
diabetic patients who knew nothing about A1C testing were tested for their knowledge of
laboratory testing for monitoring glucose. These subjects were then randomly selected to
participate in a study in which the objective was determine the difference in congenital
heart disease risk between diabetic women who were provided with facilities for selfmonitoring of blood glucose (intervention group) and diabetic women who were not
provided the same facilities (control group). Women in the intervention group had
significantly lower levels of A1C after 3 months than women in the control group
(Ezenwaka et al., 2014). The researchers concluded that providing diabetic patients with
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facilities to self-monitor blood glucose improved blood glucose levels and the congenital
heart disease risk profile (Ezenwaka et al., 2014).
Nurse-Led Interventions and Diabetes Management
Nurses can use a number of interventions to assist patients with diabetes in
improving blood glucose levels. Diabetes self-management and training programs (many
times conducted by nurses) have demonstrated improved clinical and psychosocial
outcomes for participants (Cook-Johnson, Parker, Clifton, Shams, & Young, 2012;
Houweling et al. 2011; Massimi et al. 2017). Nurses also provide instruction on
interpretation of laboratory results, medical compliance, foot care, and other aspects of
treatment, which all contribute to successful diabetes management.
Cook-Johnson et al. (2012) identified additional information on the role nurses
play in diabetes management. In this review, the effects of nurse-led interventions on
blood glucose levels and associated comorbidities were examined. No evidence was
found to suggest that nurse-led care improved Hgb A1C levels for patients with type 2
diabetes. However, evidence was found of significant improved outcomes, such as
reduced blood pressure and LDL cholesterol levels (Cook-Johnson et al., 2012).
Gaps in Literature
Gaps in the literature are evident related to a standardized protocol for Hgb A1C
monitoring as a tool for diabetes management. Although monitoring is respected as the
gold standard for accurate monitoring of blood glucose levels and an essential component
of effective diabetes management (Jones, 2013), the problem remains that currently no
standardized protocol exists for how monitoring is used. The literature supports diabetes
patient knowledge of the Hgb A1C test and laboratory testing for blood glucose as
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improving their self-management and A1C levels (Heisler, 2005; Yang et al. 2014).
However, despite such support, there are no systematic literature reviews for this
monitoring tool for diabetes management.
Possible Reasons Why Hgb A1C May Not Be Used
Diagnostic criteria for Hgb A1C must be validated and conducted through a
standardized procedure approved by the National Glycohemoglobin Standardization
Program3 (Malkani & Mordes, 2011). Test results can be 0.5% lower or higher
compared to a real percentage; a value of 7.0% Hgb A1C can be actually between ~6.5
and 7.5% (NIDDK, 2014). In addition, experts have cautioned about misleading results
if the test is conducted on people with coexisting hemolytic anemia, iron deficiency,
hemoglobinopathies, renal ailments, and/or acute hepatic (Goldenberg & Punthakee,
2013). Despite these cautions, Hgb A1C monitoring should be initiated as a standard of
care. Notice can be given for people who are suffering from other ailments, and the Hgb
A1C values obtained can be considered in diagnosis (Jones, 2013).
Summary
A guide that employs the use of Hgb A1C monitoring to manage diabetes and
improve glycemic control continues to be necessary as diabetes becomes more prevalent.
Such a guide is an easy, cost-effective way to achieve diabetes management goals where
healthcare resources are limited. Hgb A1C testing to pinpoint blood glucose levels more
precisely than other forms of glucose testing is highly effective and considered the gold
standard, not only for diagnosis of diabetes but also for POCT and self-management.
With Hgb A1C monitoring, clinicians will discover, in real time, the status of
patient blood glucose levels. Healthcare providers may then immediately modify
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treatments and institute interventions, thereby reducing the devastating effects of
comorbidities which may develop due to damage of the microvascular and macrovascular
systems of the body. The current lack of a standardized protocol of Hgb A1C monitoring
for diabetes management emphasizes the need for such a protocol.

25

Chapter 3
Methods
This chapter explains the methodology used to implement this DNP project. The
methods were subdivided to address the focus and purpose of the project. The chapter
provides information related to project design and the activities for subject selection and
recruitment, in addition to how data were collected, managed, and analyzed; determine
retrospectively the healthcare providers’ ordering, monitoring, and follow-up
appointments for adult diabetic patients with abnormal Hgb A1Cs; to develop and
implement a standardized process for healthcare providers to monitor and follow these
patients, especially those with possible non-clinical follow-up compliance and abnormal
Hgb A1C; to determine prospectively healthcare providers’ ordering, monitoring, and
follow-up appointments; and to evaluate the prospective charts to determine if Hgb AIC
results changed from abnormal to normal or elevation over time until the next follow-up
appointment.
Approximately 75% of the diabetic patients at the primary care center attended
clinic appointments and showed an improvement in blood glucose levels after the
standardized guide was implemented. The investigator compared one dependent variable,
Hgb A1C, to two independent variables that monitored Hgb A1C levels and clinic
follow-ups prior to and following a standardized guideline for providers’ implementation.
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Project Design
To evaluate the quality improvement project, two data analysis methods were
used: (a) a frequency test to determine appointment adherence retrospectively and
prospectively; and (b) a nonparametric quantitative paired t test (two-tailed) to monitor
patients diagnosed with poorly controlled diabetes who were treated in the clinic over the
course of the 3-month time spans between March 1 through May 31, 2017, and June 1
through August 31, 2017. This approach was selected because the data were readily
available, practical in terms of cost and time expended, and allowed for the collection of
data from a relatively large number of cases.
Setting
The project took place at a family practice primary care clinic located in
Brooklyn, New York. The clinic serves a multicultural population of low-income, highrisk chronic disease individuals, especially those with diabetes. Approximately 80% of
the patients have been diagnosed with diabetes.
Population and Sample Selection
The project population consisted of two groups. Group 1 was comprised of with
various levels of healthcare providers (N = 7), such as MD, APRN, RN, diabetic
educator, nutritionist, and receptionist, with 5 or more years of diabetic experience and
average age of 45. Group 2 was comprised of diabetic patients with abnormal Hbg A1C
levels and inconsistent follow-up appointments ordered and monitored by providers (N =
99). The patients’ records were reviewed retrospectively and prospectively.
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Sampling Strategy and Determination of Sample Size
A convenience sample of healthcare providers and medical records that met the
inclusion criteria was used in the QI. A priori calculation of sample size for the medical
records was carried out with G*Power (Heinrich-Heine-Universität Düsseldorf, 2014) for
dependent t test analysis. With input parameters of a two-tailed test, alpha = 0.05, power
= 0.80, and an anticipated medium effect size, d = 0.05, the required sample size was a
total of 99 records.
Inclusion Criteria
The inclusion criteria for this project for the first group was that the healthcare
providers had to be MDs, APRNs, RNs, or similar licensed providers; and had to be
employed for at least 4 weeks at the primary care center and render diabetic services.
The inclusion for the second group was that the electronic medical records (retrospective
and prospective) had to be of diabetic patients with abnormal Hgb A1C and inconsistent
clinic follow-up appointments between March 1 through August 31, 2017, who were seen
by the healthcare providers at the center.
Exclusion Criteria
The exclusion criteria for the first group applied to all healthcare providers who
did not work for the primary care center in diabetic services and who worked less than 4
weeks at the center. The exclusion criteria for the second group was the electronic
medical records of patients with normal Hgb A1C and consistent clinic follow-up
appointments, as well as these characteristics for dates other than March 1 through
August 31, 2017.
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Ethical Considerations
This quality improvement project was reviewed by the Institutional Review Board
(IRB) of Nova Southeastern University (NSU) and the human subjects’ rights board at
the primary care center where the project was conducted. A letter of exemption was
granted by the NSU IRB (Appendix A) because human subjects were not used in the
project implementation. A letter of support was provided by the primary care center
(Appendix B).
Project Phases/Objectives
This project was structured to meet the following objectives:
Objective 1: Conduct a retrospective electronic medical record review of adult
diabetic patients with abnormal Hgb A1Cs who failed to return for follow-up
appointments between March and May 2017.
This objective was accomplished by a review of adult diabetic patients’ electronic
medical records (N = 99) with abnormal Hgb A1C and inconsistent follow-up clinic
appointments between March 1 and May 31, 2017. The investigator conducted a
frequency test to determine consistency.
Objective 2: Develop and implement a standardized process for healthcare
providers to closely monitor and follow adult diabetic patients especially those with
possible nonclinic follow-up compliance and abnormal Hgb A1C.
This objective was completed by incorporation of the CDC (2016) standardized
diabetic management guideline to enhance providers’ consistency with ordering and
monitoring diabetic patients’ Hgb A1C and follow-up clinic appointments.
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Phase 1: A standardized diabetic guideline was developed to include the
CDC (2016) standards for improving healthcare delivery and healthcare outcomes
associated with Hgb A1C normalcy and follow-up consistency (Appendix C).
Phase 2: The standardized diabetic guideline was announced to the
healthcare providers (Appendix D) and presented and implemented at the primary care
center to increase diabetic management knowledge affiliated with ordering and
monitoring Hgb A1C and clinical follow-up.
Objective 3: Conduct a prospective electronic medical record review of
the same retrospective adult diabetic patients whose Hgb A1C was ordered and
monitored between June 1 and August 31, 2017.
This objective was completed in two steps:
Step 1: EMRs (N = 99) were prospectively reviewed to determine if
providers ordered and monitored Hgb A1C in conjunction with the implemented
standardized diabetic guideline.
Step 2: EMRs (N = 99) were prospectively reviewed to
determine if diabetic patients were consistent or inconsistent with clinic follow-up
appointments. This step was accomplished by the investigator conducting a frequency
test to determine prospectively if clinic appointments demonstrated consistency or not.
Objective 4: Evaluate the EMR charts prospectively to determine if the diabetic
patients’ Hgb AIC results in changes from abnormal to normal or elevation over time
until the next follow-up appointment.
This objective was accomplished by review of the electronic medical records (N
= 99) prospectively between June 1 and August 31, 2017, to determine clinic
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appointment consistency and Hgb A1C normalcy. The investigator conducted a
frequency test to determine appointment consistency and a nonparametric paired t test to
determine Hgb A1C normalcy.
Timeline
The project took place over 16 weeks. Objective 1 was completed at the end of
Week 1. Objective 2 was completed by the end of Week 3, including both the
development and implementation phases of the standardized guideline. Objective 3 was
completed by the end of Week 12, and Objective 4 was completed by the end of Week
16, including project phases and data analysis.
Resources/Budget
The project costs included an educational session that incorporated CDC (2016)
standardized recommendations for diabetic management and diagnostic monitoring.
Tokens of appreciation were given to all healthcare providers who participated in the
project (N = 7). The total cost for the project was $310. Table 1 displays all itemized
costs.
Summary
This chapter described the project methods. The purpose of the project was to
determine retrospectively healthcare providers’ ordering, monitoring, and follow-up
appointments for adult diabetic patients with abnormal Hgb A1Cs; develop and
implement a standardized process for healthcare providers to monitor and follow these
patients, especially those with possible nonclinic follow-up compliance and abnormal
Hgb A1C.
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Table 1
Project Resources and Budget

Category

Item

Description

Quantity

Total

Printing
Services

Paper, ink, and
custom printing
and binding

Guidelines for
intraprofessional
team and staff

15

$20.00

Staff
Appreciation

Luncheon

Intraprofessional
team and staff

$10.00 x 15

$150.00

Appreciation
token for staff

Gift card

$20.00 x 7

$140.00

Total Costs

$ 310.00

Additionally, the purpose was to determine prospectively healthcare providers’
ordering, monitoring, and follow-up appointments; and evaluate the prospective charts to
determine if Hgb AIC results changed from abnormal to normal or elevation until the
next follow-up appointment. At a family practice primary care clinic in Brooklyn, New
York, two groups were utilized: healthcare providers with experience treating diabetics
(N = 7) and diabetic patients (N = 99).
Frequency tests were used to determine appointment adherence retrospectively
and prospectively. A nonparametric quantitative paired t test was used to measure
patients diagnosed with poorly controlled diabetes who were treated over two 3-month
timespans. Ethical considerations were met: The IRB of Nova Southeastern University
provided a letter of exemption because human subjects were not involved in project
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implementation (Appendix A), and the primary care center provided a letter of support
(Appendix B). The project was completed with four objectives and several steps.
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Chapter 4
Results and Discussion
In accordance with the CDC (2016) recommendations, providers managing
diabetic patients with standardized practice and best healthcare delivery systems can
positively influence health outcomes. This quality improvement project reviewed adult
diabetic patient’s electronic medical records at two different periods, retrospectively and
prospectively, to determine if healthcare providers ordered and monitored Hgb A1C and
follow-up clinic appointments in accordance with standardized practice and whether
patients improved.
Outcome Measures
Data Analysis Procedures
To ensure that the data were entered without error, a frequency table was
generated to detect the margin of error + -5 values. When accuracy of data entry had
been determined, the data were evaluated for outlying scores, defined as extreme
individual scores that were at least three standard deviations above or below the mean of
the group. These scores were detected by use of frequency distribution and box plots.
Extreme scores were identified and retained.
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Descriptive statistics were used to describe the sample and report the measures of
central tendency of the variables. First, demographic information was analyzed and
reported with frequencies and percentages. Then, a two-tailed paired t test was used to
compare the retrospective and prospective scores. The results for the dependent variable
healthcare providers’ reports, were reported as measures of central tendency. Histograms
for the distribution of scores for the dependent variable and the Kolmogorov-Smirnov (KS) statistic were explored to assure the data met the assumption of normal distribution
necessary for parametric testing. Levene’s test was used to test of the assumption of
homogeneity of variance.
Patients’ Demographic Characteristics
Descriptive statistics were collected for patients’ demographic characteristics
related to diabetes. These were patients’ ages at the time of data collection, ages at
diagnoses of diabetes, and number of years living with diabetes. Table 2 illustrates the
results.
The age range of the 99 patients at review varied from 17 to 83, with the median
age 60; half the patients (50%) were above the age of 60. Three-quarters (75%) of the
patients were above the age of 41.
The age at which diabetes was diagnosed ranged from 12 to 82, with the median
age 47; half of the patients were diagnosed after reaching the age of 47. Three-quarters of
the patients were diagnosed after reaching the age of 36.
The number of years patients were living with diabetes ranged from 0 (less than 1
year) to 28 years. The median years living with diabetes was 11; half of the patients had
been living with diabetes for more than 11 years.
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Table 2
Patients’ Demographic Characteristics (N = 99)

Patients’ Age

Age Diagnosed

Years Living With
Diabetes

Median

60

47

11

Range

66

70

28

Minimum

17

12

0

Maximum

83

82

28

25th Percentile

41

36

5

50th Percentile

60

47

11

75th Percentile

71

60

15

Value

Outcome Variable
One outcome variable, Hgb A1C, for adult diabetic patients was measured and
compared at two different periods: March 1 through May 31, 2017; and June 1 through
August 31, 2017. The first period took place prior to the implementation of standardized
practice for healthcare providers at the primary care center. The 3-month chart review of
the EMR revealed an insufficiency in care standardization and healthcare provider
follow-up for Hgb A1C and clinic appointments. The Hgb A1C test results are reported
as percentages (Table 3).
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Table 3
A1C Results, Retrospective: March 1-May 31, 2017 (N = 99)
Patients’ Age

Age Diagnosed

Median

60

47

A1C Range

66

70

6

A1C Minimum

17

12

7

AlC Maximum

83

82

13

Value

A1C

A1C Mean

8.17

Standard Deviation

1.33

25th Percentile

41.00

36.00

8.00

50th Percentile

60.00

47.00

9.00

75th Percentile

71.00

60.00

10.00

For the retrospective period March 1 through May 31, 2017, the A1C scores for
99 patients were recorded and ranged between 7 and 13 with an average of 8.17. Half of
the patients’ A1Cs were above 9, with three-quarters above 8. The data collected from the
EMR were exported to an Excel spreadsheet and transferred to SPSS for analysis. Data
analysis procedures followed Field’s (2009) guidelines.
The second period took place following the implementation of standardized
practice for healthcare providers at the primary care center. All 99 patients were given
appointment dates for 3 months following their visits between March and May. The A1C
scores for 62 of the 99 patients were recorded during the 3-month period of June 1 to
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August 31, 2017, and 62.6% kept the appointments. The Hgb A1C test results are
reported as percentages (Table 4).
Table 4
A1C Results, Prospective: June 1-August 31, 2017 (N =62)
Patients’ Age

Age Diagnosed

Median

60

47

A1C Range

66

70

5.50

A1C Minimum

17

12

6.50

AlC Maximum

83

82

12.00

Value

A1C

A1C Mean

9.28

Standard Deviation

1.03

25th Percentile

41.00

36.00

7.50

50th Percentile

60.00

47.00

8.00

75th Percentile

71.00

60.00

9.00

For the prospective period June 1 to August 31, 2017, the patients’ A1C scores
ranged between 6.5 and 12, with an average of 9.28. Half of the patients had A1C above
8; three-quarters had A1C above 7.5. The decrease in AlC levels indicated greater
providers’ utilization and patients’ adherence to the recommended guidelines, and the
increase in follow-up appointments indicated enhanced care continuity.
Testing the Data
In this quality improvement project, the investigator sought to determine if there
was a difference in one dependent variable, Hgb A1C, measured at two points in time,
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prior to and after the implementation of the standardized CDC guideline for healthcare
providers’ utilization for diabetic management and practice. The Hgb A1C was
measured as continuous level data. The nonparametric t test was used to compare the
electronic medical records retrospectively and prospectively of the same diabetic patients
to determine if healthcare providers ordered and monitored Hgb A1C and clinic followup appointment with consistency. The prospective EMR review reflected healthcare
providers’ insufficiency in ordering and monitoring Hgb A1C between March 1 and May
31, 2017. Thus, a paired t test was used to determine the clinical practice outcome. The
results were considered statistically significant with a probability value (p) of less than
0.05.
Differences in Scores
The differences in A1C scores between the two 3-month period was calculated
from the EMR. Only scores for patients who attended the follow-up appointments were
used. The total retrospective EMR reviewed were 135. However, 99 EMR met inclusion
criteria between March 1 and May 31, 2017, which served as the project benchmark for
CDC (2016) 3-month standards until normalcy and clinic follow-up appointment
consistency.
Table 5 illustrates the differences in Hgb A1C scores. As the table shows, 29%
showed no A1C improvement even with the healthcare providers ordering and
monitoring. However, 71% of the follow-up patients’ Hgb A1C scores improved in the
June to August period when compared to their previous scores of the March to May
period. The differences in Hgb A1C scores ranged from -4.5 to 2, with an average
improvement in A1C score of -1.32.

39
Table 5

Value

Mar-May A1C

June-Aug A1C

Difference

99

62

62

0

37

37

Range

6.0

5.5

6.5

Minimum

7.0

6.5

-4.5

Maximum

13.0

12.0

2.0

Valid N
Missing N

Mean

9.28

8.17

-1.32

Standard

1.33

1.03

1.35

25th Percentile

8.00

7.50

-2.00

50th Percentile

9.00

8.00

-1.00

75th Percentile

10.00

9.00

0.00

Deviation

Differences in Hgb AlC Scores Retrospectively and Prospectively

Of the 99 prospectively reviewed EMR between June 1 and August 31, 2017,
37 patients did not keep their follow-up appointments, and 66 patients kept their followup appointments, for a response rate of 63%. This percentage reflected an improvement
in healthcare providers’ ordering and monitoring
of Hgb A1C after implementation of the CDC standardized guideline. Table 6 illustrates
the differences in consistency of follow-up appointments.
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Table 6
Differences in Follow-Up Appointments Retrospectively and Prospectively

Difference

Frequency

Percent

Valid Percent

Improved

44

44.4

71.0

Did Not Improve

81

18.2

29.0

Total

62

62.6

100.0

Missing

37

37.4

Total

99

100.0

Test for Significance
To test for significant differences between the two periods, a Wilcoxon Signed
Rank Test (paired nonparametric t test) was conducted. Tables 7 and 8 illustrate the
results. The p value was 0.00, which is less than the declared 0.05 p value. The p of 0.00
found showed that the difference is A1C scores of patients who attended their follow-up
appointments was significant. Thus, it can be concluded that the difference in scores was
associated with the intervention of the second 3-month period.
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Table 7
Wilcoxon Signed Ranks Test for Significance: March-May and June-August

Ranks

N

Mean Rank

Sum of Ranks

Negative Ranks

2a

19.50

39.00

Positive Ranks

44b

23.68

1042.00

Ties

16c

Total

62

a

Mar-May A1C < Jun-Aug A1C.
Mar-May A1C > Jun-Aug A1C.
c
Mar-May A1C = Jun-Aug A1C.
b

Table 8
Nonparametric Analysis

Mar-May A1C – Jun-Aug A1C

Z

-5.512a

Asymp. Sig. (2-tailed)

0.00*

a

Based on negative ranks.
*p < .05.
Discussion
The project results indicated success in the use of a standardized guideline for
healthcare providers’ monitoring A1C scores of patients. Hgb A1C scores went down for
a significant number of patients with healthcare providers ordering and monitoring. The
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providers’ frequency of ordering and monitoring Hgb A1C and follow-up appointments
improved. Based on the improvement of patients’ A1C levels, the healthcare providers
increased their ordering, monitoring, and follow-ups.
Limitations
Several limitations are acknowledged for this project. The data were collected at
only one facility, and therefore the results cannot be generalized to a more global
environment. The samples of the employees and EMR were not randomly selected,
further limiting generalizability to similar conditions. Further, the implementation took
place at a single point in time, lacking a longitudinal component for practice engagement.
This limitation may have influenced providers’ healthcare delivery and patients’
healthcare outcomes.
Additionally, although healthcare providers’ careful surveillance of Hgb A1C
ordering and monitoring was investigated, other factors that influenced Hgb A1C results
and clinic follow-up appointment consistency were not considered. These factors may
have included the healthcare professionals’ actual experiences with diabetic patients and
accuracy of chart notations. Possibly also some healthcare providers ordering and
monitoring may have been influenced by the investigator’s clinical presence, which
reminded providers to implement CDC standards and recommendations. The
investigator’s presence may have precipitated the Hawthorne effect (Goodwin et al.,
2017), in which providers may have changed their behavior knowing they were being
observed. This effect is not a new phenomenology, but can change the outcome of
observed behaviors.
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Strengths
Project strengths included the extended body of knowledge surveyed for
healthcare providers, especially for nurses to incorporate standardized guidelines for care
consistency at diabetic care clinic. The project’s success also established a foundation for
future clinic change through the utilization of theory and practice specifically for chronic
diseases such as diabetes. The knowledge and results of this project can benefit future
research and policy adaptability and feasibility for change in evidence-based practice.
The changes apply especially to healthcare outcomes for Hgb A1C ordering, monitoring,
and clinic follow-up appointments managed by healthcare providers in all areas of
specializations.
Conclusion
Diabetes mellitus is a chronic disease for which there is no cure (NIDDK, 2016).
A major option is management (NIDDK, 2016). Healthcare providers associated with
this DNP project, including nurse practitioners, incorporated standardized practice for
ordering and monitoring diabetic patients after the implementation of CDC (2014)
standardized recommendations and guideline. A retrospective electronic medical records
review revealed that healthcare providers were inconsistent in care management related
to the ordering and monitoring for diabetic patients with abnormal Hgb A1C and
inconsistent clinic appointment follow-ups. However, after intervention, both the Hgb
A1C levels and appointment follow-ups improved.
The lack of appropriate healthcare provider management of diabetic patients can
lead to other healthcare complications. The monitoring of patients for Hgb A1C levels
with a prospective chart review was a simple yet viable approach that assisted healthcare
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practitioner with helping patients to achieve blood glucose normalcy and clinic
appointment follow-up consistency after the implementation of standardized practice.
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Appendix C
Standardized Guide

MEDICAL URGENT PC- FAMILY PRACTICE
POLICY/PROCEDURE
Subject: Monitoring abnormal A1C follow-up appointment
Effective Date: 3/3/2017

Revision Date:

Supers
cedes:

Distribution: MD, DO, PA, APRN, RN
PURPOSE:
To insure healthcare provider’s incorporate CDC standards for ordering
and monitoring adult diabetic patients Hgb A1C and clinic follow-up
consistency.
POLICY:
Providers delivering care to adults diagnosed or at risk for diabetes must
incorporate CDC standardized practice for ordering and monitoring Hgb
A1C for both care continuity at clinic follow-up and self-management. The
provider:









Order and monitor abnormal Hgb A1C quarterly or frequently
depending on the non-normalcy results.
Help educate ways to reduce elevated Hgb A1C levels.
Minimize patients’ risk for abnormalcy by incorporating
assessment, interventions, and surveillance.
Community-based team interaction with primary care providers,
pharmacist, dietitian, case managers, and educators to help
improve patient’s weight loss and A1C values.
Integrate the three key objectives for care delivery: (1) optimize
provider and team behavior; (2) support patient behavior change;
& (3) change the system of care, especially to include ordering,
monitoring, and clinic follow-up appointment consistency.
Direct care in a timely manner based on evidence-based guidelines.
Make sure the care model is based on a patient-centric approach
that guides care consistency.
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Documentation and Limitations









All A1C management steps will be maintained through standardization
competency.
At the end of the clinical visit, the provider will distribute “The
Diabetes Education Program – Understand Your A1C” brochure with
cultural reflective insight for patient understanding and adherence; the
documentation system or record will include cultural awareness
language that drove patient’s compliance; and at a minimum the
provider should provide cultural references that incorporate
standardize evidence-based practice.
A follow-up process should be implemented by the provider that
identify the patient’s name, cultural preference, and/or identifier for
enhancing care competence and treatment standardization.
Educate staff regarding patient follow-up processes through the use of
a standardized monitoring system.
Consider conducting periodic chart review to evaluate the
effectiveness of the established process for patient, case management
driven.
Staff should assess the clinical important of the appointment, the
severity of the patient medical condition, and the risk(s) associated
with the missed appointment to determine appropriate follow-up
Develop a process for the follow-up of patients who have missed
appointments.
The appropriate skills providers must be present for the use for
A1C Management





Provide a delivery services that include respect, health belief practices
and linguistic needs of diver for patients.
Integrate Diabetes Care Standards and principles for the care of person
with or at risk for diabetes elevated or lower A1C
Assess a patient’s communication skills and belief systems prior to
developing a treatment plan

PROCEDURE:


Initial Assessment
o Include cultural norms and ethical practices in conjunction with regulatory
standards



Monitor microalbumin as per standardized protocol



Testing will be done as specified by regulatory standards implemented through
the protocol:
a. Annually for anyone diagnosed with prediabetes.
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Twice a year for individuals with type 2 diabetes who do not use insulin and
whose diabetes is within the goal set by their doctor.
c. Three to four times annually for individuals with type 1 diabetes.
d. Four times yearly for individuals with type 2 diabetes who use insulin and
whose condition is not under control
b.



Patients will be disease managed especially those who have missed more than one
appointment. A letter will be mail to remind them of a rescheduled follow-up
visit.



A patient-family centered care approach that provides information on diabetes,
treatment rationale, importance of medical follow-up, and how to incorporate
and/or avoid certain cultural meals that can reduce diabetic-related conditions but
enhance quality of life and well-being.

RESOURCES:
Healthcare providers will include various educational resources. For patient-family
best disease prevention, health maintenance, and quality of life sustainability; twothree resources will be provided. Resources will be provide based on patient/family
social determinants: living environment; economic sustainability; age; educational
level, etc.










American Academy of Family Physicians: Management of Newly Diagnosed
Type 2 Diabetes Mellitus in Children and AdolescentsExternal Link Disclaimer
The American Association of Clinical Endocrinologists: Clinical Practice
GuidelinesExternal Link Disclaimer
American College of Physicians: Comparative Guideline Table: Screening for
DiabetesExternal Link Disclaimer
American Diabetes Association: 2016 Standards of Medical Care in
DiabetesExternal Link Disclaimer
American Heart Association: Diabetes MellitusExternal Link Disclaimer
The American Geriatrics Society: Guidelines for Improving the Care of Older
Adults with Diabetes MellitusExternal Link Disclaimer
Endocrine Society: Clinical Practice GuidelinesExternal Link Disclaimer
National Committee for Quality Assurance: Diabetes Recognition
ProgramExternal Link Disclaimer
U.S. Preventive Services Task Force: Published RecommendationsExternal Link
Disclaimer
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